Shanghai Xuerong Bio-Technology Co Ltd (300511) - Net Assets
Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) has net assets worth CN¥1.17 Billion CNY (≈ $171.73 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.61 Billion ≈ $527.99 Million USD) and total liabilities (CN¥2.43 Billion ≈ $356.26 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Shanghai Xuerong Bio-Technology Co Ltd to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.17 Billion |
| % of Total Assets | 32.53% |
| Annual Growth Rate | 6.63% |
| 5-Year Change | -59.3% |
| 10-Year Change | 28.05% |
| Growth Volatility | 32.54 |
Shanghai Xuerong Bio-Technology Co Ltd - Net Assets Trend (2012–2024)
This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Shanghai Xuerong Bio-Technology Co Ltd to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below shows the annual net assets of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. For live valuation and market cap data, see how much is Shanghai Xuerong Bio-Technology Co Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥823.32 Million ≈ $120.48 Million |
-42.52% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.60 Million |
-11.90% |
| 2022-12-31 | CN¥1.63 Billion ≈ $237.91 Million |
-1.74% |
| 2021-12-31 | CN¥1.65 Billion ≈ $242.11 Million |
-18.21% |
| 2020-12-31 | CN¥2.02 Billion ≈ $296.00 Million |
+16.26% |
| 2019-12-31 | CN¥1.74 Billion ≈ $254.60 Million |
+10.82% |
| 2018-12-31 | CN¥1.57 Billion ≈ $229.73 Million |
+10.84% |
| 2017-12-31 | CN¥1.42 Billion ≈ $207.26 Million |
+9.81% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.75 Million |
+100.60% |
| 2015-12-31 | CN¥642.99 Million ≈ $94.09 Million |
+21.55% |
| 2014-12-31 | CN¥529.00 Million ≈ $77.41 Million |
+22.03% |
| 2013-12-31 | CN¥433.49 Million ≈ $63.43 Million |
+13.73% |
| 2012-12-31 | CN¥381.15 Million ≈ $55.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Xuerong Bio-Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 395.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥1.40 Billion | 149.51% |
| Total Equity | CN¥938.63 Million | 100.00% |
Shanghai Xuerong Bio-Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Shanghai Xuerong Bio-Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Care Property Invest NV
BR:CPINV
|
$523.34 Million |
|
Hangzhou Century Co Ltd
SHE:300078
|
$523.46 Million |
|
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SHE:300501
|
$523.49 Million |
|
IDI S.C.A.
PA:IDIP
|
$523.70 Million |
|
Wuxi Hodgen Technology Co Ltd
SHE:300279
|
$523.18 Million |
|
ODDITY Tech Ltd. Class A Ordinary Shares
NASDAQ:ODD
|
$523.17 Million |
|
Shenzhen Kingsun Science Tech
SHE:300235
|
$523.11 Million |
|
Dingli Communications Corp Ltd
SHE:300050
|
$523.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Xuerong Bio-Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,554,529,572 to 938,628,712, a change of -615,900,860 (-39.6%).
- Net loss of 617,070,813 reduced equity.
- Dividend payments of 67,006,895 reduced retained earnings.
- Other factors increased equity by 68,176,848.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-617.07 Million | -65.74% |
| Dividends Paid | CN¥67.01 Million | -7.14% |
| Other Changes | CN¥68.18 Million | +7.26% |
| Total Change | CN¥- | -39.62% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Xuerong Bio-Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.97x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.75x to 2.97x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥3.19 | CN¥5.58 | x |
| 2018-12-31 | CN¥3.61 | CN¥5.58 | x |
| 2019-12-31 | CN¥4.05 | CN¥5.58 | x |
| 2020-12-31 | CN¥4.60 | CN¥5.58 | x |
| 2021-12-31 | CN¥3.78 | CN¥5.58 | x |
| 2022-12-31 | CN¥3.47 | CN¥5.58 | x |
| 2023-12-31 | CN¥3.12 | CN¥5.58 | x |
| 2024-12-31 | CN¥1.88 | CN¥5.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Xuerong Bio-Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -65.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.54%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 4.11x
- Recent ROE (-65.74%) is below the historical average (-4.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 19.43% | 12.10% | 0.57x | 2.80x | CN¥59.86 Million |
| 2016 | 8.17% | 10.49% | 0.41x | 1.92x | CN¥-23.42 Million |
| 2017 | 8.82% | 9.20% | 0.35x | 2.77x | CN¥-16.31 Million |
| 2018 | 9.65% | 8.20% | 0.47x | 2.48x | CN¥-5.43 Million |
| 2019 | 12.66% | 11.22% | 0.51x | 2.21x | CN¥46.28 Million |
| 2020 | 12.16% | 11.23% | 0.48x | 2.24x | CN¥43.84 Million |
| 2021 | -18.47% | -14.97% | 0.48x | 2.60x | CN¥-476.11 Million |
| 2022 | -16.48% | -12.38% | 0.57x | 2.34x | CN¥-461.55 Million |
| 2023 | -12.10% | -7.33% | 0.56x | 2.96x | CN¥-343.52 Million |
| 2024 | -65.74% | -28.54% | 0.56x | 4.11x | CN¥-710.93 Million |
Industry Comparison
This section compares Shanghai Xuerong Bio-Technology Co Ltd's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $2,544,710,464
- Average return on equity (ROE) among peers: 10.86%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Xuerong Bio-Technology Co Ltd (300511) | CN¥1.17 Billion | 19.43% | 2.07x | $523.27 Million |
| ShenZhen Kondarl Group Co Ltd (000048) | $2.66 Billion | 29.04% | 5.59x | $1.48 Billion |
| Guangdong Guanghong Holdings Co Ltd (000529) | $1.67 Billion | 9.74% | 0.64x | $407.49 Million |
| Hunan Zhenghong Science and Technology Develop Co Ltd (000702) | $441.40 Million | -5.94% | 0.65x | $275.93 Million |
| Hefei Fengle Seed Co Ltd (000713) | $596.43 Million | 9.23% | 0.24x | $678.63 Million |
| Luoniushan Co Ltd (000735) | $1.17 Billion | -8.65% | 0.76x | $886.32 Million |
| New Hope Liuhe Co Ltd (000876) | $12.37 Billion | 21.37% | 0.75x | $4.30 Billion |
| Yuan Longping High-tech Agriculture Co Ltd (000998) | $1.23 Billion | 6.07% | 0.99x | $1.75 Billion |
| Dongrui Food Group Co Ltd (001201) | $268.03 Million | 34.67% | 0.73x | $423.24 Million |
| Jiangxi Sunshine Dairy Co Ltd (001318) | $1.27 Billion | 8.70% | 0.07x | $450.43 Million |
| Shandong Denghai Seeds Co Ltd (002041) | $3.76 Billion | 4.43% | 0.18x | $1.12 Billion |
About Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more